Latest California Healthline Stories
El aborto es el tema electoral más importante para las mujeres jóvenes, según una encuesta
Casi 4 de cada 10 mujeres menores de 30 años encuestadas en septiembre y principios de octubre dijeron que el aborto es la cuestión más importante a la hora de emitir su voto.
Abortion Emerges as Most Important Election Issue for Young Women, Poll Finds
A KFF survey found significant shifts among women voters since late spring — all in favor of Vice President Kamala Harris.
Encuesta revela que persiste la discriminación racial en la atención médica
Casi la mitad de los pacientes hispanos, los Indio americanos y los nativos de Alaska sienten que no se los respeta.
Many People of Color Worry Good Health Care Is Tied to Their Appearance
Many people from racial and ethnic minority groups brace themselves for insults and judgments before medical appointments, according to a new survey of patients that reaffirms the prevalence of racial discrimination in the U.S. health system.
Abortion Coverage Is Limited or Unavailable at a Quarter of Large Workplaces
A KFF survey of employer health benefits shows that 28% of large U.S. companies have limited or no access to abortion under company health insurance.
KFF Health News' 'What the Health?': A Not-So-Health-y GOP Debate
The first Republican presidential debate of the 2024 cycle took place without front-runner Donald Trump — and with hardly a mention of health issues save for abortion. Meanwhile, in Florida, patients dropped from the Medicaid program are suing the state for not giving them enough notice or a way to contest their being dropped from the program. Margot Sanger-Katz of The New York Times, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Victoria Knight of Axios join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
KFF Health News' 'What the Health?': The Confusing Fate of the Abortion Pill
The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA’s approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.
Most Americans Say They or a Family Member Has Experienced Gun Violence
More than 1 in 5 Americans report having been threatened with a firearm, and almost as many say they worry about gun violence every day or almost every day, a new KFF poll shows.
Ask Voters Directly, and Abortion Rights Wins Most Ballot Fights
Anti-abortion candidates have fared well in recent elections. But decades of ballot initiatives — including a half-dozen measures considered after the Supreme Court overturned Roe v. Wade last June — show that when voters are asked directly, they usually side with preserving abortion rights.
Public Health Agencies Try to Restore Trust as They Fight Misinformation
As public health departments work on improving their message, the skepticism and mistrust often reserved for covid-19 vaccines now threaten other public health priorities, including flu shots and childhood vaccines.